Freeline Therapeutics Holdings Buy Hold or Sell Recommendation
| FRLNDelisted Stock | USD 4.31 0.28 6.10% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Freeline Therapeutics Holdings is 'Not Rated'. The recommendation algorithm takes into account all of Freeline Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. In addition, we conduct extensive research on individual companies such as Freeline and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Freeline Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Freeline |
Execute Freeline Therapeutics Buy or Sell Advice
The Freeline recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Freeline Therapeutics Holdings. Macroaxis does not own or have any residual interests in Freeline Therapeutics Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Freeline Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Freeline Therapeutics Trading Alerts and Improvement Suggestions
| Freeline Therapeutics is not yet fully synchronised with the market data | |
| Freeline Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 622 K. Net Loss for the year was (49.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Freeline Therapeutics Holdings currently holds about 90 M in cash with (64.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. |
Freeline Therapeutics Returns Distribution Density
The distribution of Freeline Therapeutics' historical returns is an attempt to chart the uncertainty of Freeline Therapeutics' future price movements. The chart of the probability distribution of Freeline Therapeutics daily returns describes the distribution of returns around its average expected value. We use Freeline Therapeutics Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Freeline Therapeutics returns is essential to provide solid investment advice for Freeline Therapeutics.
| Mean Return | -0.09 | Value At Risk | -13.11 | Potential Upside | 14.23 | Standard Deviation | 10.43 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Freeline Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Freeline Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Freeline . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Freeline Therapeutics Buy or Sell Advice
When is the right time to buy or sell Freeline Therapeutics Holdings? Buying financial instruments such as Freeline Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Freeline Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |